Delivery Order SPE2DB20D2104-SPE2DB25FMWKT
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 40 mg capsules (30-count) on July 23, 2025, with a ceiling value of $1,713.18 and completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The product will be delivered...
- The Defense Logistics Agency awarded a $1,858.83 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 20 mg capsules (90-count unit). This is a firm fixed-price contract with an ultimate completion date of July 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating the contract was competitively awarded. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,916.54 to AmerisourceBergen Drug Corp for esomeprazole magnesium delayed-release 20 mg capsules (90-count) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,250.11 firm fixed-price delivery order is for the supply of 4560693988 - Esomeprazole Magnesium Delayed-Release 40mg Capsules in 30-count bottles. The contract has an ultimate completion date of April 25, 2023 and was awarded on April 24, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,623.92 firm fixed-price delivery order is for 4,566,938,055 units of esomeprazole magnesium delayed-release 40 mg capsules. The contract has an ultimate completion date of January 16, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Esomeprazole Magnesium Delayed-Release capsules. The $1,338.91 fixed-price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen will provide these prescription medications to support military treatment facilities and other government healthcare programs. This delivery order is part of a larger Indefinite...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,170 to Amerisourcebergen Drug Corporation for esomeprazole magnesium delayed release capsules. Under this contract, Amerisourcebergen will deliver 30 capsules of the 40mg dosage to a facility in Conshohocken, Pennsylvania by June 22, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order supports the Defense Logistics Agency's mission to provide...
- The Defense Logistics Agency awarded a $69,181 delivery order to Amerisourcebergen Drug Corporation for esomeprazole magnesium delayed-release capsules. Under this firm fixed price contract, Amerisourcebergen will provide 90,000 capsules of the heartburn medication to a Conshohocken, Pennsylvania location by July 12, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately one thousand thirty dollars to Amerisourcebergen Drug Corporation for the supply of thirty capsules of esomeprazole magnesium delayed release forty milligram medication. The single day contract has a period of performance from July 11th through July 12th, 2023 with all work taking place in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals to the Department of Defense, this order for...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,158,716 units of the medication Esomeprazole Magnesium Delayed-Release 40 mg Capsules. The award has a ceiling value of $2,439.58 and a period of performance through May 7, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWKTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Esomeprazole Magnesium Delayed-Release 40 mg capsules (30-count) with a contract value of $1,660.95. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a non-competitive set-aside award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency and Defense Health Agency demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains on a competitive basis. This delivery order for gastrointestinal medication represents a routine transaction within the company's broader federal supply mission to support military personnel and defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/24/25 |